Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share…
Novartis announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing…
Read More...
Read More...